Siesing, C., Sorbye, H., Dragomir, A., Pfeiffer, P., Qvortrup, C., Pontén, F., . . . Eberhard, J. (2017). High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer. PLoS One.

Siesing, Christina, Halfdan Sorbye, Anca Dragomir, Per Pfeiffer, Camilla Qvortrup, Fredrik Pontén, Karin Jirström, Bengt Glimelius, and Jakob Eberhard. "High RBM3 Expression Is Associated With an Improved Survival and Oxaliplatin Response in Patients With Metastatic Colorectal Cancer." PLoS One 2017.

Siesing, Christina, et al. "High RBM3 Expression Is Associated With an Improved Survival and Oxaliplatin Response in Patients With Metastatic Colorectal Cancer." PLoS One 2017.